Federal contract award
DTFASA17C00649
IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Transportation |
| Office | 697DCK REGIONAL ACQUISITIONS SVCS |
| NAICS | 334511 — Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing |
| PSC | 5840 — Radar Equipment, Except Airborne |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS INCENTIVE FEE |
| Obligations | $60.8M |
| Current contract value | $60.8M |
| Potential contract value / ceiling | $60.8M |
| Start date | Aug 31, 2017 |
| Current end date | Dec 31, 2026 |
| Potential end date | Dec 31, 2026 |
| Latest award activity | Jun 25, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 43 of 43 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 25, 2026 | P00042 | $0 | ACTBI-6 MODE 5 PERIOD OF PERFORMANCE EXTENSION |
| Dec 20, 2024 | P00041 | $2.9M | THE PURPOSE OF THIS MODIFICATION IS TO CORRECT INCREMENTAL FUNDING ON CLIN 0013 AND ADD CLIN 0015 FOR THE NON-IFF SUPPORT INSTALLATION. |
| Nov 6, 2024 | P00040 | $100.0K | THE PURPOSE OF THIS MODIFICATION IS TO CORRECT INCREMENTAL FUNDING ON CLIN 0013 AND ADD CLIN 0015 FOR THE NON-IFF SUPPORT INSTALLATION. |
| Sep 25, 2024 | P00039 | $95.3K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLIN 0013 FOR THE NON-IFF SUPPORT AND ADD ADDITIONAL TRAVEL FUNDS TO CLIN 0014 |
| Sep 12, 2024 | P00038 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE END DATE OF THE PERIOD OF PERFORMANCE FROM SEPTEMBER 30, 2024 TO SEPTEMBER 30, 2025 TO SUPPORT NON-IFF HARDWARE UPGRADES AND SPARE PARTS MODIFICATION(S) |
| Jul 17, 2024 | P00037 | $312.2K | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING TO LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| May 14, 2024 | P00036 | $44.4K | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING TO LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Feb 28, 2024 | P00035 | $1.9M | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING TO LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Feb 9, 2024 | P00034 | $306.0K | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING TO LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Dec 21, 2023 | P00033 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE UNUSED EXPIRING FY18 FUNDS FROM CONTRACT DTFASA-17-C-00649 FOR ACCBI-6 MODE 5. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Dec 20, 2023 | P00032 | $650.0K | THE PURPOSE OF THIS MODIFICATION IS TO INCREASE THE CONTRACT CEILING, EXTEND THE PERIOD OF PERFORMANCE AND OBLIGATE ADDITIONAL FUNDS. |
| Dec 12, 2023 | P00031 | $400.0K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE UNUSED EXPIRING FY18 FUNDS FROM CONTRACT DTFASA-17-C-00649 FOR ACCBI-6 MODE 5. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 25, 2023 | P00029 | $266.6K | OBLIGATE INCREMENTAL FUNDING IN THE AMOUNT OF $266,587.49, IN SUPPORT OF LINE ITEM 00014 TRAVEL FOR ACCBI-6 MODE 5. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 25, 2023 | P00030 | $-6.4K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE UNUSED EXPIRING FY18 FUNDS FROM CONTRACT DTFASA-17-C-00649 FOR ACCBI-6 MODE 5. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 21, 2023 | P00028 | $402.5K | INCREASE CEILING FOR LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS TO $45,127,952.00 AND OBLIGATE INCREMENTAL FUNDING IN THE AMOUNT OF $773,407.87. THE CONTRACT CEI |
| Sep 1, 2023 | P00027 | $773.4K | INCREASE CEILING FOR LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS TO $45,127,952.00 AND OBLIGATE INCREMENTAL FUNDING IN THE AMOUNT OF $773,407.87. THE CONTRACT CEI |
| Jul 18, 2023 | P00026 | $795.6K | OBLIGATE $795,649.26 TO FULLY FUND LINE ITEM 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS IN THE AMOUNT OF $43,952,000.00. THE CONTRACT CEILING REMAINS UNCHANGED AT $55,178, |
| Apr 4, 2023 | P00025 | $0 | CEILING INCREASE AND ADDITIONAL INCREMENTAL FUNDING AND NTE (CLIN 00001) IN INCREASE IN THE TOTAL AMOUNT OF $43,952,000 INCREMENTAL FUNDED AMOUNT FUNDED $1,800,000 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION |
| Mar 29, 2023 | P00024 | $2.0M | CEILING INCREASE AND ADDITIONAL INCREMENTAL FUNDING AND NTE (CLIN 00001) IN INCREASE IN THE TOTAL AMOUNT OF $43,952,000 INCREMENTAL FUNDED AMOUNT FUNDED $1,800,000 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION |
| Sep 26, 2022 | P00023 | $2.7M | CEILING INCREASE AND ADDITIONAL INCREMENTAL FUNDING AND NTE (CLIN 00001) IN INCREASE IN THE TOTAL AMOUNT OF $42,930,440.86 INCREMENTAL FUNDED AMOUNT FUNDED $2,741,909.88 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALU |
| Aug 15, 2022 | P00022 | $1.1M | ADDITIONAL FUNDING AND NTE INCREASE IN THE TOTAL AMOUNT FUNDED $1,059,213.00 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Jul 18, 2022 | P00021 | $551.2K | ADDITIONAL FUNDING AND NTE INCREASE IN THE TOTAL AMOUNT FUNDED $551,243 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Jul 1, 2022 | P00020 | $400.0K | ADDITIONAL FUNDING AND NTE INCREASE IN THE TOTAL AMOUNT FUNDED $400,000 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Apr 27, 2022 | P00019 | $1.3M | ADDITIONAL FUNDING IN THE TOTAL AMOUNT FUNDED $1,259,454.00 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. |
| Mar 30, 2022 | P00018 | $600.0K | ADDITIONAL FUNDING IN THE TOTAL AMOUNT FUNDED $720,000 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. PERIOD OF PERFORMANCE CLIN 0001 FOR CONTRACT 30 SEP |
| Mar 10, 2022 | P00017 | $720.0K | ADDITIONAL FUNDING IN THE TOTAL AMOUNT FUNDED $720,000 IN SUPPORT OF CLIN 00001 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. PERIOD OF PERFORMANCE CLIN 0001 FOR CONTRACT 30 SEP 20 |
| Sep 22, 2021 | P00016 | $1.5M | FUNDING IN SUPPORT OF CLIN 00001, FOR MILESTONE 3.3 IN THE AMOUNT OF $883,400, MS 4 IN THE AMOUNT OF $2,920,000 AND MS 5 PARTIAL FUND OF $1,573,295.86. FUNDING IN SUPPORT OF CLIN 00014 IN THE AMOUNT OF $100,000 TOTAL AMOUNT FUNDED $5,476,735.86 FOR |
| Aug 11, 2021 | P00015 | $3.8M | FUNDING IN SUPPORT OF CLIN 00001, FOR MILESTONE 3.3 IN THE AMOUNT OF $883,400, MS 4 IN THE AMOUNT OF $2,920,000 AND MS 5 PARTIAL FUND OF $1,573,295.86. FUNDING IN SUPPORT OF CLIN 00014 IN THE AMOUNT OF $100,000 TOTAL AMOUNT FUNDED $5,476,735.86 FOR |
| Apr 14, 2021 | P00014 | $1.8M | FUNDING IN SUPPORT OF CLIN 00001, FOR MILESTONE 3.3 IN THE AMOUNT OF $883,400, MS 4 IN THE AMOUNT OF $2,920,000 AND MS 5 PARTIAL FUND OF $1,573,295.86. FUNDING IN SUPPORT OF CLIN 00014 IN THE AMOUNT OF $100,000 TOTAL AMOUNT FUNDED $5,476,735.86 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. PERIOD OF PERFORMANCE CLIN FOR CONTRACT 26 APR 2022. |
| Sep 23, 2020 | P00013 | $5.5M | FUNDING IN SUPPORT OF CLIN 00001, FOR MILESTONE 3.3 IN THE AMOUNT OF $883,400, MS 4 IN THE AMOUNT OF $2,920,000 AND MS 5 PARTIAL FUND OF $1,573,295.86. FUNDING IN SUPPORT OF CLIN 00014 IN THE AMOUNT OF $100,000 TOTAL AMOUNT FUNDED $5,476,735.86 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. PERIOD OF PERFORMANCE CLIN FOR CONTRACT 26 APR 2022. |
| Jun 26, 2020 | P00012 | $3.7M | FUNDING IN SUPPORT OF CLIN 00001, THROUGH MILESTONE 2, 3.1 AND 3.2, IN THE AMOUNT OF $3,733,000.00 FOR DESIGN, DEVELOPMENT, QUALIFICATION, TESTS AND EVALUATION AND LIMITED PRODUCTION OF ATCBI-6 MODE 5 UPGRADE KITS. PERIOD OF PERFORMANCE FOR MILESTONE 2 IS OCT 30 2020. |
| Sep 25, 2019 | P00011 | $793.0K | MODE 5 ATCBI-6M UPGRADE - INCREMENTAL FUNDING CLIN 0001 AND TWO SIMULATOR PURCHASE FOR TESTING. |
| Jul 16, 2019 | P00010 | $5.6M | MODE 5 ATCBI-6M UPGRADE POP EXTENSION, CEILING AND ADDITIONAL FUNDING |
| Jun 14, 2019 | P00009 | $939.0K | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE ADDITIONAL FUNDING |
| May 3, 2019 | P00008 | $600.9K | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Apr 4, 2019 | P00007 | $0 | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Apr 1, 2019 | P00004 | $500.0K | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Apr 1, 2019 | P00005 | $-600.0K | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Apr 1, 2019 | P00006 | $600.0K | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Dec 11, 2018 | P00003 | $0 | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Sep 26, 2018 | P00002 | $5.2M | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Aug 29, 2018 | P00001 | $0 | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
| Aug 31, 2017 | 0 | $12.6M | IGF::CL,CT::IGF MODE 5 ATCBI-6M UPGRADE |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-12-31 (67 days from calculation)
- +35 points
- 5 historical awards in this buyer and category group
- +15 points
- 43 recorded award transactions
- +10 points
- Latest award action: 2026-06-25
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.